Genomic alterations and the incidence of brain metastases in advanced and metastatic non-small cell lung cancer: a systematic review and meta-analysis
CS Gillespie, MA Mustafa, GE Richardson… - Journal of Thoracic …, 2023 - Elsevier
Background Brain metastases (BM) in patients with advanced and metastatic non-small cell
lung cancer (NSCLC) are linked with poor prognosis. Identifying genomic alterations …
lung cancer (NSCLC) are linked with poor prognosis. Identifying genomic alterations …
Immunotherapy and brain metastasis in lung cancer: connecting bench side science to the clinic
A Rios-Hoyo, E Arriola - Frontiers in Immunology, 2023 - frontiersin.org
Brain metastases (BMs) are the most common form of intracranial malignant neoplasms in
adults, with a profound impact on quality of life and traditionally associated with a dismal …
adults, with a profound impact on quality of life and traditionally associated with a dismal …
[HTML][HTML] Use of radiation therapy among patients with Extensive-stage Small-cell lung cancer receiving Immunotherapy: Canadian consensus recommendations
Objectives Thoracic radiation therapy (TRT) and prophylactic cranial irradiation (PCI) are
commonly used in the management of extensive-stage small-cell lung cancer (ES-SCLC); …
commonly used in the management of extensive-stage small-cell lung cancer (ES-SCLC); …
[HTML][HTML] Radiomics of metastatic brain tumor as a predictive image biomarker of progression-free survival in patients with non-small-cell lung cancer with brain …
Background and objective Epidermal growth factor receptor (EGFR)–targeted tyrosine
kinase inhibitors (TKIs) are the first-line therapy for EGFR-mutant non-small-cell lung cancer …
kinase inhibitors (TKIs) are the first-line therapy for EGFR-mutant non-small-cell lung cancer …
Similar Efficacy Observed for First-Line Immunotherapy in Racial/Ethnic Minority Patients With Metastatic NSCLC
M Lee, J Liu, E Miao, S Wang, F Zhang, J Wei… - Journal of the National …, 2023 - jnccn.org
Background: Limited data exist on the impact of immunotherapy use in ethnic minority
patients with non–small cell lung cancer (NSCLC), because they have been …
patients with non–small cell lung cancer (NSCLC), because they have been …
Factors associated with cancer-related cognitive impairment in patients with lung cancer: A systematic review
HOU Tianxue, P Wenting, HO Mu-Hsing… - European Journal of …, 2024 - Elsevier
Purpose Cognitive impairment is common in lung cancer patients and impacts their quality
of life. Little is known about the etiology of cognitive impairment in lung cancer patients …
of life. Little is known about the etiology of cognitive impairment in lung cancer patients …
Targeting the Hippo pathway to prevent radioresistance brain metastases from the lung
J Taylor, F Dubois, E Bergot… - … Journal of Oncology, 2024 - spandidos-publications.com
The prognosis for patients with non‑small cell lung cancer (NSCLC), a cancer type which
represents 85% of all lung cancers, is poor with a 5‑year survival rate of 19%, mainly …
represents 85% of all lung cancers, is poor with a 5‑year survival rate of 19%, mainly …
[HTML][HTML] Five-year sustained complete remission with minimal adverse effects following radiosurgery for 2-cm brain metastasis with deep eloquent location from lung …
K Ohtakara, M Nakao, H Muramatsu, K Suzuki - Cureus, 2023 - ncbi.nlm.nih.gov
In single-fraction (sf) stereotactic radiosurgery (SRS) for brain metastases (BM) from lung
adenocarcinoma (LAC), a marginal dose of≥ 22-24 Gy is generally deemed desirable for …
adenocarcinoma (LAC), a marginal dose of≥ 22-24 Gy is generally deemed desirable for …
Parotid metastases from primary lung cancer: Case series and systematic review of the features
R Wang, T Wang, Q Zhou - Frontiers in Oncology, 2022 - frontiersin.org
Most parotid metastases have been reported to come from the head and neck; however,
cases metastasized from the lung are extremely rare. Missed diagnoses and misdiagnoses …
cases metastasized from the lung are extremely rare. Missed diagnoses and misdiagnoses …
An Evaluation of Risk Factors for Intracranial Metastases of Sarcomas: A Systematic Review and Meta-Analysis
A Nguyen, A Nguyen, C Fleeting, A Patel, N Bazett… - World Neurosurgery, 2024 - Elsevier
Introduction Sarcomas, a group of neoplasms comprising both tissue and bone soft tissue
tumors, has an increasing prevalence in recent years. Prognosis significantly hinges on …
tumors, has an increasing prevalence in recent years. Prognosis significantly hinges on …